Chinese Journal of Experimental Traditional Medical Formulae  CN: 11-3495/ISSN：1005-9903（Print）、2097-1494（Online）is sponsored by the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and the China Association of Chinese Medicine, with the National Administration of Traditional Chinese Medicine as its supervising authority. It was first published in 1995 and is now a biweekly journal, with an annual publication volume of approximately 800 articles.

Chinese Journal of Experimental Traditional Medical Formulae aims to report the latest research findings and advancements in traditional Chinese medicine (TCM) prescriptions and their major constituent drugs. It covers research related to TCM theory, methods, prescriptions, and pharmacology, delving into the compatibility patterns, material basis, and mechanisms of action of Chinese herbal compound formulations. The journal ensures the quality and clinical efficacy of Chinese herbal medicines, promotes the inheritance and development of TCM, facilitates the translation of TCM research achievements, and supports the international dissemination of TCM.

The field of formulary studies features dedicated sections including "Classic Prescriptions", "Drug Combinations", "Textual Research", "Standard Decoctions", "Mechanisms and Molecular Basis of TCM Compound Therapies", "TCM Characteristic Advantageous Diseases", and "Animal Models of TCM Syndromes". Permanent columns include Special Reviews, Classic Prescriptions, Drug Combinations, Pharmacology, Toxicology, Clinical Applications, Drug Metabolism, Formulation and Processing Techniques, Resources and Quality Evaluation, Data Mining, Academic Discussions, and Reviews.

Chinese Journal of Experimental Traditional Medical Formulae has been listed as a "Grade T1 Journal in the Chinese Medicine Science and Technology Journal Classification Directory (No.1 in Traditional Chinese Medicine Category)", "China Core Journal (No.3 in China Medicine Category)", "China Science and Technology Core Journal (No.1 in Traditional Chinese Medicine Category, Core IF 3.11)", "CSCD Source Journal (Core Database)", "RCCSE Authoritative Academic Journal (A+)", "Science and Technology Journal World Impact Index (WJCI Q1 Zone Journal)", and "China Academic Journal Impact Factor Annual Report Statistical Source Journal (CNKI Composite IF 5.474)". It has been awarded as a China Premium Science and Technology Journal, 2024 China International Influence Outstanding Academic Journal, and China Science and Technology Journal Excellence Action Plan Phase II Chinese Leading Journal.

Included in renowned international databases: Chemical Abstracts (CA) of the United States, Scopus database of the Netherlands, Medical Abstracts database of the Netherlands, Japan Science and Technology Agency (JST) database, Ulrich's Periodicals Directory (UPD) of the United States, and WHO Western Pacific Regional Medical Index (WPRIM).

The editorial board currently consists of 171 leading scholars and experts from both domestic and international disciplines.

Chief Editor Wu Yiling, Deputy Chief Editors Chen Shilin, Guo De'an, Guo Lanping, Liu Jianxun, Liu Liang, Lü Aiping, Sun Xiaobo, Wang Guochen, Wang Jie, Wang Xijun, Xiao Wei, Xiao Xiaohe, Xie Tian, Yang Hongjun, Zhu Xiaoxin.